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Summary
The Saccharomyces cerevisiae chromatin silencing factor Sir2 suppresses genomic instability and extends replicative life
span. In contrast, we find that mouse embryonic fibroblasts (MEFs) deficient for SIRT1, a mammalian Sir2 homolog,
have dramatically increased resistance to replicative senescence. Extended replicative life span of SIRT1-deficient MEFs
correlates with enhanced proliferative capacity under conditions of chronic, sublethal oxidative stress. In this context,
SIRT1-deficient cells fail to normally upregulate either the p19ARF senescence regulator or its downstream target p53.
However, upon acute DNA damage or oncogene expression, SIRT1-deficient cells show normal p19ARF induction and cell
cycle arrest. Together, our findings demonstrate an unexpected SIRT1 function in promoting replicative senescence in
response to chronic cellular stress and implicate p19ARF as a downstream effector in this pathway.Introduction
The Saccharomyces cerevisiae chromatin silencing factor Sir2
(silent information regulator 2) is an NAD-dependent histone
deacetylase that suppresses transcription at several genomic
loci (Blander and Guarente, 2004). In addition, Sir2 suppresses
recombination at the ribosomal DNA array, thereby extending
yeast life span (Blander and Guarente, 2004; Kaeberlein et al.,
1999; Sinclair and Guarente, 1997). Because of its NAD depen-
dence, the activity of Sir2 is linked to the energy status of the
cell, providing a mechanism whereby cellular metabolism can
influence life span. Overexpression or pharmacologic activa-
tion of Sir2 homologs in Caenorhabditis elegans and Drosoph-
ila melanogaster also extends life span (Astrom et al., 2003;
Rogina and Helfand, 2004; Tissenbaum and Guarente, 2001;
Wood et al., 2004). Seven mammalian Sir2 homologs, referred
to as SIRT1-7, have been identified (Frye, 2000). Based on this
conserved function in regulating life span in lower eukaryotes,
mammalian Sir2 homologs have been proposed to play a sim-
ilar role (Kaeberlein et al., 1999). As SIRT1 is a nuclear protein
and is the mammalian homolog most highly related to Sir2, it
has been the focus of a large body of recent studies.
SIRT1-deficient mice suffer multiple abnormalities, including
defects in spermatogenesis and in heart and retina develop-
ment (Cheng et al., 2003; McBurney et al., 2003). The highly
pleiotrophic phenotype of SIRT1-deficient mice likely reflects
the broad array of potential SIRT1 substrates (reviewed in
Blander and Guarente [2004]). In some cells, SIRT1 inhibits
apoptosis in response to genotoxic stress and may accomplishCELL METABOLISM : JULY 2005 · VOL. 2 · COPYRIGHT © 2005 ELSEVIthis by several mechanisms. SIRT1 deacetylates the p53 tumor
suppressor protein (Cheng et al., 2003; Langley et al., 2002;
Luo et al., 2001; Tissenbaum and Guarente, 2001; Vaziri et al.,
2001), which downregulates p53 via effects on stability and ac-
tivity (Prives and Manley, 2001). SIRT1 also inhibits apoptosis
and promotes DNA repair by deacetylating FOXO transcription
factors (Brunet et al., 2004; Daitoku et al., 2004; Motta et al.,
2004; Van Der Horst et al., 2004), and it inhibits Bax-induced
apoptosis by deacetylating Ku70 (Cohen et al., 2004a). Expres-
sion of SIRT1 itself is activated by calorie restriction and acute
nutrient withdrawal and, thus, may promote cellular adaptation
to metabolic stress (Cohen et al., 2004b; Nemoto et al., 2004).
As increased stress resistance is a frequent correlate of longev-
ity in model organisms (Finkel and Holbrook, 2000), the ability
of SIRT1 to modulate stress resistance in mammalian cells
suggests a potential link with mammalian aging.
Cellular senescence has been employed as a model for
mammalian aging (Campisi, 2000; Hayflick and Moorhead,
1961). This process, which can be induced by several stimuli,
consists of a state of permanent cell cycle arrest associated
with characteristic changes in cell morphology. Human and
mouse fibroblasts undergo a limited number of divisions in cul-
ture, eventually entering a state of cellular senescence known
as replicative senescence (Campisi, 2000; Hayflick and Moor-
head, 1961). In human fibroblasts, replicative senescence re-
sults from telomere attrition. In contrast, mouse embryonic fi-
broblasts (MEFs), which possess much longer telomeres than
human cells, undergo replicative senescence as a result of
sublethal oxidative damage incurred under standard cultureER INC. DOI 10.1016/j.cmet.2005.06.007 67
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and DePinho, 2000; Wright and Shay, 2000). Cellular senes-
cence also may represent a tumor suppressor mechanism, pre-
venting propagation of cells that incur potentially oncogenic
mutations (Krtolica and Campisi, 2002). In this regard, a senes-
cence-like state, termed premature senescence, is induced by
introduction of activated oncogenes into primary fibroblasts
(Serrano et al., 1997). Likewise, acute DNA damage in primary
fibroblasts, as induced by various genotoxins, also triggers cel-
lular senescence (Chen et al., 1995; Robles and Adami, 1998;
Sedelnikova et al., 2004).
In MEFs, the p53 protein plays a critical role in promoting
senescence via activation of a complex transcriptional program
(Oren, 2003; Vousden and Lu, 2002). Activation of p53 by the
p19ARF tumor suppressor protein promotes replicative senes-
cence. In this case, oxidative stress triggers p19ARF induction,
which positively regulates p53 via inhibition of MDM2, a protein
that mediates p53 degradation (Kurokawa et al., 1999; Pomer-
antz et al., 1998; Zhang et al., 1998; Zindy et al., 1998). Consis-
tent with the importance of the p19ARF/p53 pathway in replica-
tive senescence, spontaneous immortalization of MEFs during
culture usually results from adaptive mutations in p53 or silenc-
ing of p19ARF (Kamijo et al., 1997; Sherr and DePinho, 2000).
Like replicative senescence, premature senescence in re-
sponse to activated oncogenes also is mediated by p19ARF-
dependent activation of p53 (Palmero et al., 1998). In this con-
text, MEFs immortalized through mutations in the p19ARF/p53
pathway are transformed, rather than growth arrested, by intro-
duction of activated oncogenes (Kamijo et al., 1997; Serrano
et al., 1997). Finally, cellular senescence induced by acute DNA
damage also is mediated by p53, but via a pathway that is
independent of p19ARF (Kamijo et al., 1997; Stott et al., 1998).
Potential roles of SIRT1 with respect to replicative senes-
cence in mammalian cells have not been elucidated. However,
certain findings have supported the notion that SIRT1, like
yeast Sir2, might function to prevent senescence. In this re-
gard, p53 is hyperacetylated in SIRT1-deficient MEFs (Cheng
et al., 2003), and increased p53 acetylation has been associ-
ated with senescence (Pearson et al., 2000). Likewise, overex-
pression of SIRT1 inhibits oncogene-induced premature se-
nescence in MEFs (Langley et al., 2002). On the other hand,
total p53 protein levels are reduced in SIRT1-deficient MEFs
(Cheng et al., 2003), an effect that could potentially inhibit se-
nescence. Here, we have directly assessed the effect of SIRT1
deficiency on replicative senescence of MEFs. In marked con-
trast to Sir2 function in S. cerevisiae, we find that SIRT1 pro-
motes replicative senescence in MEFs and that p19ARF is a
novel downstream effector of SIRT1 in this pathway.
Results
SIRT1 deficiency abrogates replicative senescence
We have previously described SIRT1-deficient (referred to as
S1KO) mice and S1KO MEFs (Cheng et al., 2003). To explore
the role of SIRT1 in replicative senescence, we subjected
S1KO and (wild-type) wt control MEFs to serial passage ac-
cording to a 3T3 protocol (Todaro and Green, 1963). As pre-
viously shown, wt cultures underwent growth arrest after five68to eight passages (Figure 1A) (Todaro and Green, 1963). Sur-
prisingly, rather than arresting earlier than wt cells, S1KO cells
did not undergo replicative senescence and continued to prolif-
erate unabated (Figure 1A). Similar results were obtained with
six independent S1KO MEF lines (Figure 1A, data not shown).
The replicative capacity of MEFs can also be assessed by their
ability to form colonies when seeded at low density. In this
assay, wt MEF cultures underwent senescence before forming
visible colonies, as previously described (Bardeesy et al., 2002;
Sage et al., 2000), whereas S1KO MEF lines exhibited signifi-
cantly greater clonogenic potential (Figure 1B). Similar results
were obtained for four independent S1KO and three indepen-
dent wt MEF lines. Together, these observations suggest that
SIRT1 deficiency extends, rather than shortens, the normal
replicative life span of primary mouse fibroblasts.
The increased replicative life span of SIRT1-deficient MEFs
might be due to either an acute effect of SIRT1 deficiency or
to secondary adaptations during growth of the S1KO cells in
utero or in culture. To distinguish these possibilities, we acutely
inactivated SIRT1 in cultured MEFs. We previously described
mice in which exon 4 of SIRT1 was flanked by LoxP sites
(ex4Flox) and showed that mice harboring homozygous dele-
tions of this exon were phenotypically indistinguishable from
S1KO mice (Cheng et al., 2003). This finding indicates that the
truncated SIRT1 protein generated by the exon 4 deletion allele
is nonfunctional. Ex4Flox/S1KO and ex4Flox/wt MEF lines were
generated from crosses of ex4Flox/ex4Flox mice and mice het-
erozygous for the SIRT1 null allele (wt/S1KO). Adenoviral trans-
duction of these MEFs with Cre recombinase fused to green
fluorescent protein (GFP-Cre) resulted in nearly complete exci-
sion of floxed exon 4 and replacement of the full-length SIRT1
protein by the nonfunctional, faster-migrating ex4 protein
(Figure 1C). 3T3 serial passage of multiple lines, following treat-
ment with GFP-Cre or GFP control, demonstrated that the
GFP-Cre-treated ex4Flox/S1KO cultures were strikingly resis-
tant to replicative senescence, as compared to the same lines
treated with GFP control virus or ex4Flox/wt MEFs treated with
either GFP-Cre or GFP control virus (Figure 1D). Similar results
were obtained with six additional ex4Flox/S1KO MEF lines and
three additional ex4Flox/wt MEFs lines, in either serial passage
or colony formation experiments (see Figure S1 in the Supple-
mental Data available with this article online). Thus, acute inac-
tivation of SIRT1 in MEFs confers resistance to replicative se-
nescence, demonstrating that this is a direct effect of loss of
SIRT1 function.
To further exclude potential secondary mutations as causes
of the enhanced replicative life span of S1KO MEFs, we asked
whether the effect of SIRT1 deficiency on replicative life span
could be reversed by exogenous SIRT1 expression. Recombi-
nant SIRT1 was introduced into S1KO MEFs by retroviral trans-
duction at passage 7, a point by which wt cultures had already
senesced. Transduced SIRT1 expression occurred at levels
slightly lower than those of endogenous SIRT1 (Figure 1E).
Upon SIRT1 reconstitution, the S1KO MEF cultures showed
significantly reduced proliferative capacity compared to control
cultures treated with empty virus (Figure 1F and data not
shown). Similar results were obtained with multiple indepen-
dent late-passage S1KO MEF cultures in either serial passage
or colony formation assays (Figure S1). Notably, the deacety-
lase activity of SIRT1 is required for reversal of the enhanced
proliferation of S1KO MEFs, since a catalytically inactive SIRT1CELL METABOLISM : JULY 2005
Mammalian SIRT1 limits replicative life spanFigure 1. S1KO MEFs are resistant to culture-induced replicative senescence and show impaired passage-induced accumulation of p19ARF
A) Numbers of population doublings (PD) over serial passaging according to a 3T3 protocol, carried out in triplicate for two independent wt and S1KO cell lines. The
data is representative of six independent experiments, and for MEFs derived from multiple mouse litters, and from two independent gene-targeted disruptions of SIRT1
function (Cheng et al., 2003).
B) Colony formation upon seeding at low density (103 cells/10 cm plate). Quantitation of the average number of colonies from three independent experiments
is indicated.
C and D) Acute inactivation of SIRT1 in conditionally targeted MEFs by adenoviral Cre recombinase extends replicative life span. (C) Southern and Western analysis
of Cre deletion in ex4Flox/S1KO MEFs, following treatment with adenoviral GFP-Cre or control GFP. For Southern analysis, genomic DNA was digested with BglII and
probed with an internal EcoRI-SalI fragment (Cheng et al., 2003). Bands corresponding to nondeleted (ex4Flox) and deleted (ex4) conditional-targeted alleles are
indicated. In this Southern, the S1KO null allele results in a 3.4 kb band. For Western analysis, the wild-type (wt) and mutant (ex4) SIRT1 proteins are indicated.
(D) 3T3 serial passaging assays, in triplicate, of ex4Flox/S1KO and ex4Flox/wt lines following GFP-Cre deletion or control GFP treatment.
E and F) Reintroduction of exogenous SIRT1 into late-passage S1KO MEF cultures. (E) Western analysis of SIRT1 protein levels following reconstitution with SIRT1
(S1) or control (Co) virus, compared to endogenous levels (wt). (F) Serial passaging according to 3T3 protocol as in Figure 1. Arrow indicates retroviral transduction
with SIRT1 or empty virus control at passage 7.
In all panels, error bars indicate the standard error of the mean.CELL METABOLISM : JULY 2005 69
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S1E). Overall, these findings provide strong evidence that the
resistance of S1KO MEFs to replicative senescence is a direct
consequence of SIRT1 deficiency and not due to secondary
immortalizing mutations. This conclusion is further supported
by our finding that SIRT1 reconstitution also led to upregulation
of a downstream regulator of replicative senescence (see below).
p19ARF is a novel downstream effector of SIRT1
in regulation of replicative senescence
We previously showed that S1KO MEFs exhibited normal sen-
sitivity to ionizing radiation, to adriamycin, and to UV (Cheng
et al., 2003) (Figure S2). Thus, even though S1KO MEFs are
resistant to replicative senescence, they retain normal cell cy-
cle control in response to various forms of DNA damage. Be-
cause p19ARF is a critical senescence regulator but does not
function in acute DNA damage responses (Kamijo et al., 1997;
Stott et al., 1998), we asked whether SIRT1 regulates p19ARF
levels. Western analysis of p19ARF levels in early passage (P3)
S1KO and wt MEFs revealed that baseline levels of the p19ARF
protein were significantly lower in S1KO cells compared to wt
cells (Figure 2A, lanes 1 and 3). In contrast, there was no differ-
ence in p19ARF levels in wt and S1KO cells following treatment
with the DNA damage-inducing agent adriamycin (Figure 2A,
lanes 2 and 4). Over the course of serial passage, p19ARF accu-
mulates in wt MEFs as previously described (Zindy et al.,
1998); however, in S1KO MEFs, p19ARF accumulation was sig-Figure 2. p19ARF is a downstream effector of SIRT1 in regulation of replicative senescence
A) Western analysis of p19ARF, p53, and acetylated p53 levels in passage 3 MEFs at baseline or following treatment with 0.2 ug/ml adriamycin for 8 hr.
B) Western analysis of p19ARF, p53, and acetylated p53 levels in S1KO and wt control MEFs at passages 2, 5, and 8.
C) Reversal of p19ARF levels upon reconstitution with exogenous SIRT1 at passage 7.
D) Western analysis of p19ARF levels in SIRT1-, p53-doubly deficient MEFs.70nificantly attenuated (Figure 2B). The p19ARF protein regulates
senescence, at least in part, by stabilizing p53 (Kurokawa et
al., 1999; Pomerantz et al., 1998). Consistent with this function
of p19ARF, S1KO cells also showed attenuated accumulation of
p53 over serial passage (Figure 2B). On the other hand, p53
was hyperacetylated in S1KO cells both following DNA dam-
age (Figure 2A; Cheng et al. [2003]) and during serial passage
(Figure 2B). Thus, SIRT1 deficiency has two distinct effects on
p53: hyperacetylation and reduction in total levels.
Because silencing of p19ARF expression is commonly ob-
served during the spontaneous immortalization of wt MEFs
that occurs upon extended passage in culture (Kamijo et al.,
1997), reduced p19ARF levels in S1KO MEFs theoretically might
reflect such a random event rather than a direct functional con-
sequence of absence of SIRT1 expression. To address this is-
sue, we asked whether reconstitution of late-passage S1KO
cells with SIRT1 expression could reverse the reduced p19ARF
levels in addition to reversing their enhanced replicative poten-
tial (see Figure 1F). In three independent experiments, reconsti-
tution of S1KO MEFs at passage 7 resulted in increased levels
of p19ARF (Figure 2C) and p53 (data not shown). Therefore, we
conclude that the reduced p19ARF levels in S1KO MEFs result
from loss of a novel SIRT1 function rather than from secondary
adaptive mutations or silencing events.
Although p19ARF regulates p53 stability, p53 also appears to
regulate p19ARF in a negative feedback loop (Quelle et al.,
1995). Because SIRT1 deficiency leads to p53 hyperacetyla-CELL METABOLISM : JULY 2005
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theory, lead to selection for cells that have downregulated
p19ARF. To explore this possibility, we bred mice with homozy-
gous inactivating mutations in both SIRT1 and p53 and then
generated S1KO/p53-deficient MEFs. Assays of the doubly de-
ficient MEFs demonstrated that, even in a p53-deficient back-
ground, SIRT1 deficiency led to reduced p19ARF protein levels
(Figure 2D). Thus, the reduced levels of p19ARF in S1KO cells
cannot be attributed to feedback from p53 hyperacetylation
or an adaptation to putative p53 hyperactivity. Together, our
observations suggest that SIRT1 has a novel function in regu-
lating replicative senescence by promoting upregulation of
p19ARF.
SIRT1-deficient cells show enhanced proliferative
capacity under conditions of chronic,
sublethal oxidative stress
Because replicative senescence in MEFs is thought to be a
response to the nonphysiologic levels of oxidative stress pres-
ent in standard cell culture conditions (Parrinello et al., 2003),
we asked whether and in what context SIRT1 regulates oxida-
tive stress resistance. S1KO and wt cultures were treated with
a wide range of doses of H2O2 for 15 min and transferred to
normal media for 18 hr, and the percentage of S phase cells
was assessed by BrdU incorporation to determine the ratio of
BrdU incorporation in H2O2-treated cells compared to control-
treated cells (S phase ratio). At all doses assayed, the S phase
ratios of S1KO cells and wt control cells were indistinguishable
(Figure 3A). These data indicated that, under the conditions of
this assay, SIRT1 deficiency does not confer resistance to
acute oxidative stress. This observation was somewhat unex-
pected, given that replicative senescence is in fact a response
to oxidative stress. However, since replicative senescence re-
flects a cellular response to continuous culture under mild
chronic oxidative stress, it is conceivable that such conditions
might trigger different cellular responses than acute oxidative
insults.
To test whether S1KO MEFs have enhanced replicative po-
tential under conditions of chronic, sublethal oxidative stress,
we tested them for growth in the continuous presence of 50
M H2O2 or under serum deprivation, conditions that led to
mild oxidative stress and accelerated cell cycle arrest/senes-
cence of wt MEFs (Nemoto and Finkel, 2002) (Figure S3A). Un-
der both these conditions, S1KO MEFs proliferated signifi-
cantly better than wt MEFs (Figure 3B) and accumulated lower
levels of p19ARF (Figure 3E). Further, at the end of one week of
culture under these conditions, greater than 50% of wt MEFs
stained positive for the senescence marker SA-β-galactosi-
dase, whereas only about 10% of S1KO MEFs were SA-β-
galactosidase positive (Figure 3C). In these experiments, S1KO
or wt MEFs did not undergo apoptosis as assessed by annexin
V staining (data not shown). Together, these observations indi-
cate that the resistance of S1KO MEFs to replicative senes-
cence reflects a novel function of SIRT1 in controlling prolifera-
tive capacity under conditions of chronic, sublethal oxidative
stress.
SIRT1-deficient cells retain intact responses
to oncogenic Ras
We next asked whether SIRT1 regulates p19ARF levels and pre-
mature senescence of MEFs in response to oncogenic Ras.CELL METABOLISM : JULY 2005The activated Ras mutant H-RasV12 (or empty virus control)
was introduced into S1KO and wt MEFs by retroviral transduc-
tion and cell cycle arrest assessed by BrdU incorporation. Un-
like immortal 3T3 MEF lines (Kamijo et al., 1997), S1KO MEFs
showed entirely normal responses to H-RasV12 with respect to
cell cycle arrest (Figure 4A). We also carried out soft agar as-
says for anchorage-independent growth, a characteristic of
cellular transformation. When transduced with H-RasV12, S1KO
MEFs failed to form colonies in soft agar, like primary wt MEFs,
whereas H-RasV12-expressing immortal 3T3 lines exhibited ro-
bust anchorage-independent colony formation (Figure 4B).
Moreover, there was no significant difference in levels of
p19ARF induction in S1KO and wt MEFs (Figure 4C), indicating
that SIRT1 is dispensable for p19ARF induction in response to
H-RasV12 expression. Similar results were obtained for three
independent S1KO MEF lines. Thus, SIRT1 is required for nor-
mal p19ARF induction and cellular senescence in response to
prolonged replication but is dispensable for senescence in
MEFs following acute expression of oncogenic Ras.
Notably, S1KO cells were sensitive to H-RasV12-induced se-
nescence and resistant to H-RasV12-induced transformation,
even at very late passages (passage 50) (Figure 4B). This is in
sharp contrast to the cells that grow out of wt MEF cultures
following such extended passage, which are transformed by
activated H-RasV12 (Figure 4B). In this context, cells that have
grown out of wt MEF cultures by passage 50 had, as expected
(Kamijo et al., 1997), either lost p53-dependent induction of the
cell cycle regulator p21 (Figure 4C, WT2-3T3) or expression of
p19ARF (Figure 4C, WT1-3T3) in response to H-RasV12. In con-
trast, S1KO cultures at passage 50 (Figure 4C, KO-3T3)
showed normal p19ARF and p21 induction in response to
H-RasV12. S1KO MEFs also arrested normally in response to
acute expression of p19ARF (Figures S4A and S4B), indicating
that the pathway downstream of p19ARF is functionally intact.
We also found that the p16INK4A/pRb pathway was intact in
S1KO MEFs (Figure S4B). In addition, S1KO MEFs also were
not transformed by oncogenic c-myc, in contrast to immortal
MEF lines carrying adaptive mutations (Figures S4C and S4D).
We conclude that SIRT1 deficiency allows for continued prolif-
eration of MEFs without subjecting them to selection for im-
mortalizing mutations.
Discussion
SIRT1 regulation of cellular life span via p19ARF
Our findings lead to the surprising conclusion that murine
SIRT1 and budding yeast Sir2 have opposite effects on replica-
tive senescence. Thus, while Sir2 extends replicative life span
in budding yeast, SIRT1 functions to limit the replicative life
span of MEFs. We note that, similar to our results with MEFs,
RNAi-mediated knockdown of SIRT1 dramatically extends rep-
licative life span of human primary fibroblasts (E. Michishita, I.
Horikawa, and J.C. Barrett, personal communication), docu-
menting the generality of this function across mammalian spe-
cies. We also show that alleviation of replicative senescence in
the absence of SIRT1 correlates with upregulation of p19ARF.
Because p19ARF promotes stabilization of p53, SIRT1 defi-
ciency in MEFs also impairs normal upregulation of p53 levels
during prolonged culture, which likely accounts for bypass of
senescence. However, in contrast to many mutations that con-
fer resistance to replicative senescence, SIRT1 deficiency in71
A R T I C L EFigure 3. SIRT1 regulates proliferative capacity under chronic, mild oxidative stress
A) Cell cycle arrest (S phase ratio, calculated as ratio of BrdU incorporation in treated cells compared to untreated cells) was measured 18 hr after exposure of cultures
to the indicated doses of H2O2. Data represent the mean of three independent cell lines.
B) Proliferation of cells cultured in sublethal concentrations of H2O2 (50 M) or under low serum (3%).
C and D) Senescence-associated β-galactosidase activity of cells treated as in (B).
E) Levels of p19ARF in cells treated as in (B). Co, control; LS, low serum; HP, hydrogen peroxide. In all panels, error bars indicate the standard error of the mean.MEFs leaves intact cell cycle arrest/senescence responses to
acute DNA damage, acute oxidative stress, and activated on-
cogenes. Overall, our findings also support the notion that
mammalian cells have evolved different mechanisms to re-
spond to chronic versus acute genotoxic insults (Figure 5).
Several lines of evidence indicate that the effects of SIRT1
deficiency on p19ARF and replicative senescence in MEFs are
not due to adaptive changes in S1KO cultures. First, acute in-
activation of SIRT1 by Cre-Lox strategies confers resistance to
senescence. Second, the enhanced replicative potential and
attenuated p19ARF levels of S1KO cells can be reversed by
exogenous SIRT1, even at relatively late passage, when wild-
type cultures have already senesced. Third, SIRT1 deficiency
leads to reduced p19ARF levels in a p53-deficient background,
in which there should be no selection pressure for cells ex-
pressing low levels of p19ARF. Fourth, unlike immortalized cell
lines that have acquired secondary adaptations in culture,
SIRT1-deficient MEFs retain fully functional responses to acti-
vated oncogenes and acute DNA damage that are indistin-
guishable from those of primary wild-type MEFs. We have also
found that, although SIRT1-deficient MEFs bypass senes-
cence, they do not accumulate genomic instability beyond that
observed in wild-type cells (Figure S5). These results are con-72sistent with data found in p19ARF-deficient MEFs, in which cel-
lular immortalization is not accompanied by increased genomic
instability (Kamijo et al., 1997; Zindy et al., 1997). Thus, the
similarity of the phenotypes resulting from p19ARF and SIRT1
deficiency with respect to extending MEF life span in the ab-
sence of increased genomic instability further supports our
conclusion that the effect of SIRT1 deficiency on MEF replica-
tive life span ultimately is mediated thorugh p19ARF. Together,
these findings argue that the resistance of S1KO cells to repli-
cative senescence reflects a novel, direct function of SIRT1
that influences regulation of p19ARF expression in response to
chronic genotoxic stress.
Differential regulation of p19ARF by SIRT1 distinguishes
replicative from oncogene-induced senescence
The p19ARF protein is a critical regulator of cellular senescence;
correspondingly, it is upregulated during both replicative se-
nescence and oncogene-induced premature senescence (Pal-
mero and Serrano, 2001; Zindy et al., 1998). It has been pro-
posed that replicative senescence and oncogene-induced
senescence may not be functionally distinct (Ben-Porath and
Weinberg, 2004). In this context, both processes are thought to
result from increased cellular levels of reactive oxygen speciesCELL METABOLISM : JULY 2005
Mammalian SIRT1 limits replicative life spanFigure 4. SIRT1 is dispensable for oncogene-
induced premature senescence
A) Cell cycle arrest following exposure to oncogenic
Ras. S phase ratio indicates the ratio of S phase
cells in H-RasV12-treated cells compared to control-
treated cells. Data represent average of three inde-
pendent experiments. WT3T3 indicates immortal-
ized, late-passage wt lines.
B) Representative soft agar assays of passage 6
(P6) and passage 50 (P50) S1KO and wt MEF lines
after infection with H-RasV12. Experiments were car-
ried out in triplicate. Average number of colonies fol-
lowing Ras treatment were as follows: two indepen-
dent early passage wt lines, 0.3 ± 0.6; three
independent S1KO lines, 0.3 ± 0.6; late-passage
3T3 lines derived from wt MEFs, 21.7 ± 10,
24 ± 7, 23 ± 5; late-passage 3T3 lines derived from
KO MEFs, 0.3 ± 0.6, 0.3 ± 0.6, 0; and NIH3T3 cells,
34.3 ± 6.7.
C) Western analysis of p19ARF and p21 protein in-
duction following infection with retroviral H-RasV12
(+) or control virus (−) in WT3T3 and S1KO3T3 lines,
derived from serial passaging according to 3T3 pro-
tocols. In all panels, error bars indicate the standard
error of the mean.senescence in response to chronic, sublethal genotoxic stress,
Figure 5. SIRT1 promotes senescence in response to prolonged replication but
not oncogene activation or acute DNA damage
Acute DNA damage insults activate p53 by p19ARF-independent mechanisms,
whereas replicative senescence, which is due to chronic, sublethal oxidative
stress, and Ras-induced premature senescence activates p53 by inducing
p19ARF. Our new findings indicate that SIRT1 is required for p19ARF induction only
during replicative senescence, in response to chronic, sublethal genotoxic stress.(ROS) (Irani et al., 1997; Lee et al., 1999; Parrinello et al., 2003;
Sundaresan et al., 1996). However, we now show that SIRT1 is
required for normal upregulation of p19ARF during replicativeCELL METABOLISM : JULY 2005but it is not required for activated Ras-induced premature se-
nescence. One conceivable mechanism by which these two
processes might differ would be by triggering different levels
of ROS. However, we found that both forms of stress induction
in MEFs led to similar intracellular levels of ROS (Figure S3).
Thus, the differential involvement of SIRT1 in replicative versus
oncogene-induced senescence points to a fundamental dis-
tinction in the pathways underlying these phenomena, even
though both are ultimately mediated by p19ARF (see model,
Figure 5). In this regard, while genotoxic stress is the primary
trigger for replicative senescence, increased ROS levels is only
one of several consequences of mitogenic signaling evoked by
activated Ras (Irani et al., 1997).
We can tentatively rule out several potential mechanisms by
which SIRT1 might regulate p19ARF in the context of replicative
senescence of MEFs. In particular, SIRT1 does not function
directly to deacetylate p19ARF based on assays with available
anti-acetyl lysine antibodies (data not shown). Also, direct reg-
ulation of histones at the p19ARF promoter by SIRT1 seems
unlikely to account for reduced p19ARF levels in S1KO cells,
since histone hyperacetylation should increase, rather than de-
crease, p19ARF expression. Thus, we suspect that SIRT1 may
target, directly or indirectly, an upstream p19ARF regulator.
Such a putative SIRT1 substrate could be part of the senes-
cence response to chronic genotoxic stress or, alternatively,
could regulate the induction of the senescence response itself.
In the latter context, the lack of p19ARF accumulation in S1KO
cells could simply reflect the failure of these cells to accumu-
late a threshold level of genotoxic stress required to initiate the
replicative senescence response.
The regulation of p19ARF by SIRT1 could occur transcription-
ally or posttranslationally. Several negative regulators of repli-73
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been identified, including the polycomb group proteins Bmi-1,
Cited2, and Twist; the transcription factors Tbx2 and Tbx3
(Carlson et al., 2002; Jacobs et al., 2000; Jacobs et al., 1999;
Kranc et al., 2003); and the recently identified Pokemon factor
(Maeda et al., 2005). However, unlike the putative SIRT1-regu-
lated factor, negative regulation of p19ARF by these factors
counteracts Ras-induced premature senescence and cooper-
ates with Ras to promote oncogenic transformation. In addi-
tion, our preliminary experiments have not revealed hyperacet-
ylation of several of these known factors in S1KO cells. At the
posttranslational level, there is evidence that p19ARF protein
undergoes ubiquitin-dependent degradation (Kuo et al., 2004),
and SIRT1 might deacetylate a factor involved in regulating
p19ARF stability. However, the E2/E3 ubiquitination factors that
regulate p19ARF turnover have yet to be identified. Thus, the
identity of the putative SIRT1 target that influences replicative
senescence remains unknown.
Our findings demonstrate that SIRT1 expression can influ-
ence p53 function via two distinct mechanisms, which have
opposite effects on net p53 activity. Thus, SIRT1 inactivates
p53 by deacetylation but can lead to p53 induction via regula-
tion of p19ARF. We suggest that, in the context of replicative
senescence in S1KO MEFs, reduced p53 levels outweigh the
effects of p53 hyperacetylation. In contrast, following acute
DNA damage in SIRT1-deficient thymocytes, p53 levels are un-
affected, and p53 hyperacetylation renders the cells hypersen-
sitive to DNA damage (Cheng et al., 2003). Similarly, over-
expression of SIRT1 deacetylates p53 in MEFs following
activated Ras expression and, thereby, appears to attenuate
the senescence response (Langley et al., 2002). Therefore, as
we observed no effect of SIRT1 deficiency on total p19ARF and
p53 levels following activated Ras expression in MEFs (Figure
4C and data not shown), p53 hyperacetylation in these cells
might be predicted to lead to a hyperactive senescence re-
sponse. However, we could not assay for such a hyperactive
response, because premature senescence of wt MEFs occurs
almost immediately following transduction and selection for
activated Ras expression. Overall, our current findings, cou-
pled with previous work, suggest that the effect of SIRT1 on
net cellular p53 activity may be dependent on both cell type
and the context of cellular stress.
Perspective: cellular senescence, mammalian
aging, and SIRT1
Based on the ability of Sir2 to extend life span in lower eukary-
otes, SIRT1 has been considered an attractive pharmacologi-
cal target in humans. However, the divergence of yeast Sir2
and mouse SIRT1 functions in replicative senescence high-
lights potential difficulties with this generalization. In this re-
gard, the relationship between cellular senescence and organ-
ismal aging clearly differs in unicellular and multicellular
organisms. In unicellular yeast, cellular senescence is, by defi-
nition, a detrimental process, while, in mammals, cellular se-
nescence shows antagonistic pleiotropy; that is, it may be ben-
eficial in some contexts, such as tumor suppression, but
detrimental in others, such as promoting aging of mitotic tis-
sues (Campisi, 1997). Moreover, as our findings indicate that
SIRT1 has different effects on senescence depending on the
particular trigger, a detailed examination of its function in spe-
cific contexts would be critical in attempts to predict how mod-74ulation of SIRT1 activity would impact mammalian physiology
and aging.
Regardless of the role of SIRT1 in normal physiology, our
finding that “immortal” SIRT1-deficient MEFs have intact re-
sponses to acute genotoxic stress and oncogenic transforma-
tion suggests that modulation of SIRT1 activity might be useful
to grow large quantities of certain cell types for experimental
or therapeutic purposes without selecting for transforming mu-
tations. Indeed, inactivation of p19ARF can augment expansion
and long-term cultivation of mouse hepatocytes and contribute
to liver regeneration following transplantation (Mikula et al.,
2004). In addition, inhibition of p19ARF expression can promote
the self-renewal of hematopoietic stem cells, augmenting ex
vivo expansion and in vivo repopulating capacity (Iwama et al.,
2004). Thus, in these, and potentially other cell types, SIRT1
might be a useful target for pharmacologic modulation.
Experimental procedures
Culturing and retroviral reconstitution of MEFs
and 3T3 serial passaging
MEFs were cultured in DMEM supplemented with 15% fetal calf serum,
8 mM nonessential amino acids, 8 mM sodium pyruvate, 9 mM glutamine,
9 mM penicillin/streptomycin, 18 mM HEPES (pH 7), and 0.006 mM β-mer-
captoethanol. For replicative senescence assays, a 3T3 protocol (Sherr and
DePinho, 2000; Todaro and Green, 1963) was followed by counting cells in
triplicate and reseeding 3 × 105 cells per 10 cm plate every 3 days. For
colony formation assays, MEFs were seeded at a density of 103 cells per
10 cm plate and cultured for 2 weeks, and colonies were stained with crys-
tal violet. Retroviral packaging and infection was performed as previously
described (Cheng et al., 2003). For chronic H2O2 cultures, 1 × 106 cells
were plates in 2 ml media with 50 uM H2O2 lacking β-mercaptoethanol in
6-well plates, and media was replaced every day.
Generation and Cre deletion of conditionally targeted SIRT1 MEFs
Gene targeting to generate ex4Flox ES cells was previously described
(Cheng et al., 2003). ES cell clones were injected into C57BL/6 blastocysts,
founder chimeras bred to 129/Sv females, and F1 heterozygotes inter-
crossed. Resulting ex4Flox/ex4Flox mice were crossed to wt/S1KO mice, and
MEFs were isolated from embryonic day 13.5 embryos and genotyped by
Southern analysis. For Cre deletion, conditionally targeted SIRT1 MEFs
were infected with Cre-GFP and GFP adenoviruses (gift of Jonathan Walsh
and Richard Mulligan). Briefly, 1 × 106 cells were plated with 1 × 108 viral
particles (moi = 100). After 24 hr, cells were washed and fresh medium was
added. At 48 hr postinfection, the efficiency of infection was calculated
based on percentage of GFP-positive cells. Later (48 hr), cells were counted
and plated for the 3T3 passage and colony formation assays.
Western analysis
Western analysis was carried out as previously described (Cheng et al.,
2003). Antibodies included: anti-p19 (Abcam, ab80), anti-p16 (Santa Cruz),
anti-SIRT1 (Upstate), anti-α-tubulin (Sigma), anti-p53 (CM-5, Novocastra),
and anti-p21 (Ab-4, Oncogene, Ab-4). p53 acetylation was assessed using
PAbLys(Ac)379m antibody, as previously described (Cheng et al., 2003).
Soft agar assays
Anchorage-independent growth was assessed by soft agar assays, as pre-
viously described (Dannenberg et al., 2000). Briefly, 2.5 × 104 cells were
resuspended in 2 ml 0.4% low melting point agarose (Sigma) in DMEM with
13% serum and seeded into 6-well plates coated with 1% low melting point
agarose in DMEM with 10% serum. Foci were scored and photographed
after 14 days.
Cell cycle analysis
BrdU incorporation was assayed with anti-BrdU antibodies (BD Phar-
mingen) according to the manufacturer’s instructions. Briefly, 5 × 105 cells
were pulsed with BrdU for 4 hr, harvested, and stained with FITC-conju-CELL METABOLISM : JULY 2005
Mammalian SIRT1 limits replicative life spangated anti-BrdU antibodies and propidium iodide, and cell cycle profiles
were analyzed by flow cytometry.
Supplemental data
Supplemental data include five figures and can be found with this article
online at http://www.cellmetabolism.org/cgi/content/full/2/1/67/DC1/.
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